Α Case of Severe Thyroid Eye Disease Treated with Tocilizumab.

Abstract	This is a case report describing a patient with severe thyroid eye disease complicated with dysthyroid optic neuropathy that was unresponsive to intravenous steroids and orbital radiotherapy but responded well to intravenous tocilizumab.
Authors	Aysel Mehmet, Eirini Kanella Panagiotopoulou, Aristeidis Konstantinidis, Charalampos Papagoras, Panagiotis Skendros, Doukas Dardabounis, Athanasia Maria Mikropoulou, Georgios Labiris
Journal	Acta medica (Hradec Kralove) (Acta Medica (Hradec Kralove)) Vol. 64 Issue 1 Pg. 64-69 ( 2021) ISSN: 1805-9694 [Electronic] Czech Republic
PMID	33855963 (Publication Type: Case Reports, Journal Article)
Chemical References	Antibodies, Monoclonal, Humanized Steroids tocilizumab
Topics	Antibodies, Monoclonal, Humanized (therapeutic use) Graves Ophthalmopathy (drug therapy, radiotherapy) Humans Male Middle Aged Optic Nerve Diseases (drug therapy, radiotherapy) Steroids (administration & dosage) Thyroidectomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!